[Thromboembolic disease during pregnancy. 3].
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D003911:Dextrans / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010689:Phlebitis / Q000188:drug therapy*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011343:Procaine / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D003911:Dextrans; D014665:Vasodilator Agents; D014812:Vitamin K; D011343:Procaine; D006493:Heparin
Maladie thrombo-embolique en cours de grossesse. 3.